Girish Nair, MD
Clinical Cardiac Electrophysiology · Indianapolis, INNPI 1477504694
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,009 of the $8,700 with a category attached, or 80.6%. 16 manufacturers reported payments, led by Medtronic at 52.5% of the total. Reporting peaked in 2019 at $3,230 and has fallen 67.0% since, to $1,067 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in IN, where the typical reported total is $13,586.
Across 99 payments — averaging $87.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$2K
- Boston Scientific$970
- Biosense Webster, Inc.$561
- Atricure, Inc.$300
- Impulse Dynamics (USA) Inc.$183
- plus $328 from 10 others
Across 1 payment — averaging $1750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$2K
What the payments were for
- Travel & lodging$1,69119%
- Food & beverage$7,00981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 46 | $4,566 |
| Abbott | 19 | $1,791 |
| Boston Scientific | 12 | $970 |
| Biosense Webster, Inc. | 7 | $561 |
| Atricure, Inc. | 2 | $300 |
| Impulse Dynamics (USA) Inc. | 1 | $183 |
| Regeneron Healthcare Solutions, Inc. | 1 | $103 |
| Biotronik Inc. | 1 | $63 |
| Novartis | 2 | $48 |
| Pfizer | 2 | $25 |
| Amarin Pharma, Inc. | 1 | $18 |
| Amgen | 1 | $17 |
| Altathera Pharmaceuticals LLC | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$1,077
- ENSITE PRECISION$678
- OPTIMIZER$367
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$300
- Ensite Cardiac Mapping System$292
- Carto 3$224
- QUADRA ASSURA$160
- EnSite Precision Cardiac Mapping System$149
- Cobalt$140
- VIGILANT X4 CRT-D$136
- NUVISION ICE CATHETER$136
- AURORA EV-ICD MRI SURESCAN$133
- AZURE XT DR MRI SURESCAN$129
- ENSITE$128
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$127
- ALLURE QUADRA$124
- GENERAL TACHY$120
- WATCHMAN Access System$115
- SelectSecure$115
- EMBLEM$112
How this compares
$8,700 in reported general payments places this provider in the 30th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
See all clinical cardiac electrophysiology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 690 | $903,534 |
| XareltoRivaroxaban | 78 | $110,959 |
| EntrestoSacubitril/Valsartan | 62 | $87,164 |
| JardianceEmpagliflozin | 31 | $44,093 |
| MultaqDronedarone Hcl | 16 | $29,606 |
| Metoprolol Succinate | 588 | $11,476 |
| Dofetilide | 35 | $6,143 |
| Mexiletine Hcl | 45 | $4,708 |
| Flecainide Acetate | 70 | $4,703 |
| Amiodarone Hcl | 214 | $3,750 |
| SotalolSotalol Hcl | 172 | $3,265 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 69 | $2,957 |
| Valsartan | 96 | $1,885 |
| Nebivolol Hcl | 13 | $1,787 |
| Bisoprolol Fumarate | 33 | $1,495 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $25 | $903,534690 claims |
| Johnson & JohnsonXarelto | $12 | $110,95978 claims |
| NovartisEntresto | $48 | $87,16462 claims |
| Boehringer IngelheimJardiance | $14 | $44,09331 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
Other clinical cardiac electrophysiology in Indianapolis
- Eric PrystowskyIndianapolis$1.1M
- Kevin TrulockIndianapolis$402K
- Sharath VipparthyIndianapolis$114K
- Jasen GilgeIndianapolis$93K
- Vincent KeatingIndianapolis$80K
- Christopher ReedIndianapolis$80K
- Marcelle StuckyIndianapolis$76K
- Joseph SzwedIndianapolis$67K
- Krishna MalineniIndianapolis$65K
- Anil PurohitIndianapolis$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.